| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.27 | 1.27 | 1.28▼ | 1.23▲ | 1.28▼ |
| MA10 | 1.27▲ | 1.28▼ | 1.27▼ | 1.24▲ | 1.35▼ |
| MA20 | 1.28▼ | 1.27▼ | 1.26▲ | 1.29▼ | 1.51▼ |
| MA50 | 1.28▼ | 1.24▲ | 1.23▲ | 1.37▼ | 1.74▼ |
| MA100 | 1.27▲ | 1.23▲ | 1.26▲ | 1.53▼ | 1.85▼ |
| MA200 | 1.23▲ | 1.27▼ | 1.35▼ | 1.85▼ | 1.58▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | 0.000▼ | 0.004▲ | -0.023▼ |
| RSI | 45.518▼ | 51.721▲ | 56.192▲ | 44.412▼ | 39.617▼ |
| STOCH | 66.667 | 48.333 | 60.152 | 35.283 | 17.455▼ |
| WILL %R | -33.333 | -60.000 | -42.857 | -43.725 | -89.362▼ |
| CCI | -4.912 | -26.762 | -15.025 | 41.140 | -90.038 |
|
Tuesday, September 15, 2026 02:58 PM
An announcement from Ibio ( (IBIO)) is now available. In September 2026, iBio updated its corporate presentation to highlight a strategic focus on “breakthrough antibodies” for obesity and ...
|
|
Tuesday, September 01, 2026 09:30 AM
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and ...
|
|
Friday, August 28, 2026 06:06 AM
SAN DIEGO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmo ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/09/26 | 1.28 | 1.305 | 1.26 | 1.27 | 256,466 |
| 18/09/26 | 1.26 | 1.30 | 1.24 | 1.28 | 440,600 |
| 17/09/26 | 1.25 | 1.3099 | 1.21 | 1.25 | 2,067,701 |
| 16/09/26 | 1.19 | 1.20 | 1.17 | 1.18 | 406,900 |
| 15/09/26 | 1.20 | 1.22 | 1.17 | 1.19 | 375,735 |
| 14/09/26 | 1.23 | 1.23 | 1.20 | 1.20 | 323,807 |
| 11/09/26 | 1.24 | 1.24 | 1.20 | 1.205 | 184,893 |
| 10/09/26 | 1.26 | 1.26 | 1.22 | 1.225 | 302,320 |
| 09/09/26 | 1.30 | 1.30 | 1.25 | 1.26 | 404,244 |
| 08/09/26 | 1.31 | 1.32 | 1.28 | 1.30 | 190,356 |
|
|
||||
|
|
||||
|
|